Open AccessNadir Hemoglobin Levels after Discontinuation of Epoetin in Hemodialysis Patients
Author(s) -
José Antonio Calvo Gómez,
Dana C. Miskulin,
Klemens B. Meyer,
Daniel E. Weiner
Publication year - 2010
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.02650310
Subject(s) - medicine , hemodialysis , discontinuation , nadir , hemoglobin , epoetin alfa , anemia , intensive care medicine , satellite , engineering , aerospace engineering
In hemodialysis patients, both hemoglobin variability and targeting normalization of hemoglobin may have adverse consequences. There are few data on epoetin management in patients achieving high hemoglobin levels.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom